Efficacy of SRM-IV Vestibular Function Diagnosis and Treatment System in Treating Benign Paroxysmal Positional Vertigo
AbstractBackground: We determined the diagnostic and therapeutic effects of SRM-IV vestibular function diagnosis and treatment system on benign paroxysmal positional vertigo (BPPV).Methods: Overall, 120 patients with BPPV diagnosed in the outpatient and in-patient departments of the Vertigo Treatment Center of the First People's Hospital of Xuzhou from January 2013 to December 2015 were selected for this study. They were randomly divided into three groups. Automatic repositioning procedure was conducted for 40 patients in the equipment repositioning group by SRM-IV vestibular function diagnosis and treatment system, conventional manual repositioning procedure was used for 40 patients in the manual repositioning group, and combination of treatment drugs (alprostadil and safflower injection) with acclimatization training was adopted in 40 patients in the drug therapy group.Results: After 1 week of treatment, the cure rate and total effective rate in the equipment repositioning group and the manual repositioning group were significantly higher than those in drug therapy group (P<0.05). The total effective rate was 100.0% in the equipment-repositioning group and 92.5% in manual repositioning group; the difference between the two groups was not statistically significant. The success rate of one-time treatment of anterior semicircular canal BPPV, posterior semicircular canal BPPV and lateral semicircular canal BPPV in the equipment-repositioning group were higher than those in the manual repositioning group were.Conclusion: The SRM-IV vestibular function diagnosis and treatment system are helpful in achieving effective and standard diagnosis and treatment of BPPV.
Tegeler L, Blumer J (2018). OMT May Be Helpful in the Management of Benign Paroxysmal Positional Vertigo. J Am Oste-opath Assoc, 118(1): 51-52.
Rosenfeld RM, Shiffman RN (2009). Clinical practice guideline development manual: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg, 140(6): S1-43.
Aron M, Bance M (2013). Insights into horizontal canal benign paroxysmal posi-tional vertigo from a human case report. Laryngoscope, 123(12): 3197-3200.
Lbekwe TS, Rogers C (2012). Clinical evalua-tion of posterior canal benign paroxys-mal positional vertigo. Niger Med J, 53(2): 94-101.
Wei X (2016). Progress in diagnosis and treatment of benign paroxysmal posi-tional vertigo. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 30(5): 345-348.
Lin GC, Basura GJ, Wong HT, Heidenreich KD (2012). Canal switch after canalith repositioning procedure for benign par-oxysmal positional vertigo. Laryngoscope, 122(9): 2076-2078.
Wen C, Chen T, Chen F, Liu Q, Li S, Cheng Y, Lin P (2014). Investigation of the reverse phase nystagmus in position-ing test for benign paroxysmal positional vertigo. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 49(5): 384-389 [In Chi-nese].
Chen X, Li P, Gu X, Lin S, Zhang R (2011). The relevance of high stimulus rate ABR and recurrent vertigo and its clinical sig-nificance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 25(7): 289-291.
Tang H, Li W (2017). Advances in the diag-nosis and treatment of benign paroxys-mal positional vertigo. Exp Ther Med, 14(3): 2424-2430.
Nair MA, Mulavara AP, Bloomberg JJ, Sangi-Haghpeykar H, Cohen HS (2018). Visual dependence and spatial orientation in benign paroxysmal positional vertigo. J Vestib Res, 27(5-6): 279-286.
Do YK, Kim J, Park CY, Chung MH, Moon IS, Yang HS (2011). The effect of early canalith repositioning on benign paroxysmal positional vertigo on recur-rence. Clin Exp Otorhinolaryngol, 4(3): 113-117.
Gu CY, Han WW, Wu YQ, Fan ZY, Chen CJ, Chen HM (2018). Study on bone me-tabolism in postmenopausal women with idiopathic benign paroxysmal positional vertigo. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 53(2): 134-137.